NCT04941144View on ClinicalTrials.gov

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

CompletedOBSERVATIONAL
Enrollment

8,538

Participants

Timeline

Start Date

December 22, 2021

Primary Completion Date

April 28, 2023

Study Completion Date

April 28, 2023

Conditions
Coronavirus Disease (COVID-19)
Interventions
BIOLOGICAL

COVID-19 Vaccine

COVID-19 Vaccine Intramuscular Injection

Trial Locations (1)

Unknown

Moderna selected site, Tokyo

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT04941144 - Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination | Biotech Hunter | Biotech Hunter